Detection of Point Mutations Associated with Resistance of Helicobacter pylori to Clarithromycin by Hybridization in Liquid Phase

作者: Myriam Pina , Alessandra Occhialini , Lurdes Monteiro , Henry-Pierre Doermann , Francis Mégraud

DOI: 10.1128/JCM.36.11.3285-3290.1998

关键词:

摘要: When the standard procedure for determining antibiotic susceptibility of bacteria is used, results are delayed, especially that grow slowly, such as Helicobacter pylori. Treatment this bacterium may involve clarithromycin, a compound which resistance has been associated with point mutations on 23S rRNA gene. This currently found in organisms isolated from 0 to 15% patients and jeopardizes success treatment. We have designed test involving amplification colorimetric hybridization liquid phase detect mutation at molecular level. First, four reference strains, including wild type three strains A2143C, A2143G, A2144G, were used optimize method. Amplification was carried out primers previously published. The amplified products added probe-coated microtiter wells. A DNA enzyme immunoassay hybrids. optimal conditions defined each probe. Nineteen H. pylori resistant clarithromycin 22 susceptible according phenotypic data submitted restriction BsaI BbsI, part gene sequenced order determine involved strains. new assay showed complete correlation methods, except one strain. Cross-hybridizations well application reaction other did not lead optical densities higher than cutoff values chosen receiving operating characteristic curve. method can be easily standardized gives result within day. Its directly biopsy specimens or infected gastric juice planned future.

参考文章(25)
M. Bazzicalupo, S. Fancelli, DNA Extraction from Bacterial Cultures Springer, Berlin, Heidelberg. pp. 41- 45 ,(1997) , 10.1007/978-3-642-60441-6_7
A Occhialini, M Urdaci, F Doucet-Populaire, C M Bébéar, H Lamouliatte, F Mégraud, Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrobial Agents and Chemotherapy. ,vol. 41, pp. 2724- 2728 ,(1997) , 10.1128/AAC.41.12.2724
F. Mégraud, A. Lee, Helicobacter pylori: techniques for clinical diagnosis and basic research. W.B. Saunders Co. Ltd.. ,(1996)
S Fujita, B A Lasker, T J Lott, E Reiss, C J Morrison, Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood. Journal of Clinical Microbiology. ,vol. 33, pp. 962- 967 ,(1995) , 10.1128/JCM.33.4.962-967.1995
J Versalovic, D Shortridge, K Kibler, M V Griffy, J Beyer, R K Flamm, S K Tanaka, D Y Graham, M F Go, Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrobial Agents and Chemotherapy. ,vol. 40, pp. 477- 480 ,(1996) , 10.1128/AAC.40.2.477
J B Katz, A D Alstad, G A Gustafson, K M Moser, Sensitive identification of bluetongue virus serogroup by a colorimetric dual oligonucleotide sorbent assay of amplified viral nucleic acid. Journal of Clinical Microbiology. ,vol. 31, pp. 3028- 3030 ,(1993) , 10.1128/JCM.31.11.3028-3030.1993
S N Cho, G M van der Vliet, S Park, S H Baik, S K Kim, Y Chong, A H Kolk, P R Klatser, J D Kim, Colorimetric microwell plate hybridization assay for detection of amplified Mycobacterium tuberculosis DNA from sputum samples. Journal of Clinical Microbiology. ,vol. 33, pp. 752- 754 ,(1995) , 10.1128/JCM.33.3.752-754.1995
L. RODRIGO, D. STAMLER, A. ARCHAMBAULT, T. ROKKAS, N. SKANDALIS, R. FEDORAK, F. BAZZOLI, E. HENTSCHEL, P. MORA, A. ARCHIMANDRITIS, F. MEGRAUD, H. WURZER, Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer Alimentary Pharmacology & Therapeutics. ,vol. 11, pp. 943- 952 ,(1997) , 10.1046/J.1365-2036.1997.00223.X